#Biosimilars play a crucial role in improving long-term sustainability of healthcare systems across Europe. Biocon Biologics’ CEO and Managing Director, Shreehas Tambe, addresses this topic in a recent op-ed for the Winter 2025 issue of European Biopharmaceutical Review Magazine. In the piece, he acknowledges the rise in chronic diseases such as #diabetes, #cancer and #autoimmune diseases and how expanding the access of biosimilars in Europe can support health institutions to optimize the system and patient care.
 
Access his full op-ed on pages 24-25 of the digital version of European Biopharmaceutical Review (EBR) 

Review, available here: